患有系统性AL氨基粉症相关的获得X因子缺乏症的患者的出血模式和临床结果
Okan Cetin1,2, Andrew Staron1,3, Patric Teodorescu4
1Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
American journal of hematology
|September 22, 2025
概括
患有全身AL氨基粉症的患者可能会出现获得的X因子缺乏症,导致明显的出血模式并影响临床结果. 这项研究调查了这些出血特征及其与患者预后的关联.
科学领域:
- 血液学 血液学 血液学
- 内部医学 内部医学
- 在瘤学瘤学.
背景情况:
- 系统性amyloidosis是一种罕见的疾病,其特点是器官中的蛋白质沉积.
- 获得的X因子缺乏症可以发生在全身AL氨基粉症中,使患者的治疗复杂化.
- 了解出血模式对于预测临床结果至关重要.
研究的目的:
- 描述系统性AL粉样性粉症相关的获得X因子缺乏症患者的出血模式.
- 评估与这些出血事件相关的临床结果.
- 确定影响该患者群体预后的因素.
主要方法:
- 对被诊断患有全身AL氨基粉症和获得的X因子缺乏症的患者的回顾性图表审查.
- 分析出血事件的类型,严重程度和位置.
- 出血模式与治疗反应,存活率和其他临床结果的相关性.
主要成果:
- 患者表现出粘膜皮肤和胃肠道出血的高患病率.
- X因子缺乏的严重程度与增加的出血风险相关.
- 出血事件与较差的整体存活率和更高的住院率有关.
结论:
- 在全身AL氨基粉症中获得的X因子缺乏症具有显著的出血并发症.
- 及时识别和管理出血对于改善患者的治疗结果至关重要.
- 需要进一步的研究来优化这种特定并发症的治疗策略.
相关概念视频
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Endocarditis II: Clinical Features of Infective Endocarditis
358
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
358
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Clot Retraction and Fibrinolysis
8.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.2K
Extrinsic and Intrinsic Pathways of Hemostasis
11.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.7K


